| Callie Lamay Dpm Llc | |
|
767 Boston Post Rd, Old Saybrook, CT 06475-2127 | |
| (860) 388-2641 | |
| (860) 395-2928 |
| Full Name | Callie Lamay Dpm Llc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot Surgery |
| Location | 767 Boston Post Rd, Old Saybrook, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376269357 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | (* (Not Available)) | Primary |
| Provider Name | Callie Lamay |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1467581769 PECOS PAC ID: 4688850050 Enrollment ID: I20110520000028 |
News Archive
The Diatron Group, global provider of hematology and clinical chemistry analyzers, will be showing two new, bench top analyzers on booth 3A 07 at Medica, Dusseldorf (20-23 November 2013). The new version of the established Abacus 3CT hematology analyzer has been enhanced to make it even easier to use. In addition, Diatron will also be previewing a prototype version of the brand new Pictus 500 clinical chemistry analyzer.
Increased incidence of gastroesophageal reflux symptoms (GERS) reported by a large population of 9/11 World Trade Center attack survivors, most of whom had not reported any GERD-related symptoms prior to 9/11, worsened the health-related quality life for many rescue and recovery workers, lower-Manhattan residents and local workers who were exposed to the dust cloud and other contaminants in the aftermath of 9/11, according to a study published online today online today in The American Journal of Gastroenterology.
Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection.
Amgen announced today that the Cellular, Tissue and Gene Therapies Advisory Committee and the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration will jointly review the Company's Biologics License Application (BLA) for talimogene laherparepvec.
Rebleeding is rare in patients with complicated peptic ulcers after successful treatment for Helicobacter pylori infection, Spanish clinicians report.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Callie Lamay Dpm Llc 767 Boston Post Rd, Old Saybrook, CT 06475-2127 Ph: (860) 388-2641 | Callie Lamay Dpm Llc 767 Boston Post Rd, Old Saybrook, CT 06475-2127 Ph: (860) 388-2641 |
News Archive
The Diatron Group, global provider of hematology and clinical chemistry analyzers, will be showing two new, bench top analyzers on booth 3A 07 at Medica, Dusseldorf (20-23 November 2013). The new version of the established Abacus 3CT hematology analyzer has been enhanced to make it even easier to use. In addition, Diatron will also be previewing a prototype version of the brand new Pictus 500 clinical chemistry analyzer.
Increased incidence of gastroesophageal reflux symptoms (GERS) reported by a large population of 9/11 World Trade Center attack survivors, most of whom had not reported any GERD-related symptoms prior to 9/11, worsened the health-related quality life for many rescue and recovery workers, lower-Manhattan residents and local workers who were exposed to the dust cloud and other contaminants in the aftermath of 9/11, according to a study published online today online today in The American Journal of Gastroenterology.
Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection.
Amgen announced today that the Cellular, Tissue and Gene Therapies Advisory Committee and the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration will jointly review the Company's Biologics License Application (BLA) for talimogene laherparepvec.
Rebleeding is rare in patients with complicated peptic ulcers after successful treatment for Helicobacter pylori infection, Spanish clinicians report.
› Verified 6 days ago
John T. Carroll, Dpm Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 455 Boston Post Rd, Unit #8, Old Saybrook, CT 06475 Phone: 860-510-0502 Fax: 860-510-0551 | |
Callie Lamay, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 | |
Dr. John T Carroll, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 455 Boston Post Rd Ste 8, Old Saybrook, CT 06475 Phone: 860-510-0502 Fax: 860-510-0551 | |
Saybrook Podiatry Associates, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 | |
Dr. Kevin M. Wakeham, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 |